Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

WorldReplica AG

History from 18 Oct 2024

UID
CHE-229.622.324
Legal form
AG
Canton
ZH
Founded
18 Oct 2024
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 1M
252k503k755k1M11 Mar 2025 · CHF 825k12 Feb 2026 · CHF 977k7 Apr 2026 · CHF 1M20252026
  • shares

Record

  1. SHAB published 23 Oct 2024 · legal date 18 Oct 2024

    Company formed

    Founded 18 Oct 2024

    SHAB HR01-1006160548 ↗

  2. SHAB published 11 Mar 2025 · legal date 12 Feb 2025

    Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    220’000 → 825’000
    Shares
    22’000’000 → 82’500’000
    New shares, % of post-step shares
    73.3% (60’500’000 new)

    Aktienkapital neu: CHF 825'000.00 [bisher: CHF 220'000.00]. Liberierung Aktienkapital neu: CHF 825'000.00 [bisher: CHF 220'000.00]. Aktien neu: 82'500'000 Namenaktien zu CHF 0.01 [bisher: 22'000'000 Namenaktien zu CHF 0.01]. Die Gesellschaft hat mit Beschluss vom 03.03.2025 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006278366 ↗

  3. SHAB published 11 Mar 2025 · legal date 12 Feb 2025

    Capital band adopted

    SHAB HR02-1006278366 ↗

  4. SHAB published 12 Feb 2026 · legal date 6 Feb 2026

    Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    825’000 → 976’646.48
    Shares
    82’500’000 → 97’664’648
    New shares, % of post-step shares
    15.5% (15’164’648 new)

    Aktienkapital neu: CHF 976'646.48 [bisher: CHF 825'000.00]. Liberierung Aktienkapital neu: CHF 976'646.48 [bisher: CHF 825'000.00]. Aktien neu: 97'664'648 Namenaktien zu CHF 0.01 [bisher: 82'500'000 Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006567521 ↗

  5. SHAB published 7 Apr 2026 · legal date 25 Mar 2026

    Capital increase

    Capital increased

    Issued from conditional capital

    Nominal capital
    976’646.48 → 1’006’896.48
    Shares
    97’664’648 → 100’689’648
    New shares, % of post-step shares
    3.0% (3’025’000 new)

    Aktienkapital neu: CHF 1'006'896.48 [bisher: CHF 976'646.48]. Liberierung Aktienkapital neu: CHF 1'006'896.48 [bisher: CHF 976'646.48]. Aktien neu: 100'689'648 Namenaktien zu CHF 0.01 [bisher: 97'664'648 Namenaktien zu CHF 0.01].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • Shares issued out of conditional capital, as when options are exercised.−1.0

    Classifier score 0.12 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006616462 ↗

Published by 8 Oct 2026